Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Cv Sciences Inc (CVSI)

Cv Sciences Inc (CVSI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 4,280
  • Shares Outstanding, K 144,599
  • Annual Sales, $ 20,050 K
  • Annual Income, $ -15,550 K
  • 60-Month Beta 1.09
  • Price/Sales 0.25
  • Price/Cash Flow N/A
  • Price/Book 1.25
Trade CVSI with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.13
  • Most Recent Earnings -0.02 on 05/16/22
  • Next Earnings Date 08/15/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.03
  • Number of Estimates 1
  • High Estimate -0.03
  • Low Estimate -0.03
  • Prior Year -0.03
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0285 +2.46%
on 08/16/22
0.0410 -28.78%
on 07/19/22
-0.0078 (-21.08%)
since 07/15/22
3-Month
0.0285 +2.46%
on 08/16/22
0.0650 -55.08%
on 05/17/22
-0.0311 (-51.58%)
since 05/16/22
52-Week
0.0285 +2.46%
on 08/16/22
0.3298 -91.15%
on 08/17/21
-0.3008 (-91.15%)
since 08/16/21

Most Recent Stories

More News
CV Sciences, Inc. Announces Launch of PlusCBD™ Reserve Collection Softgels

/PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in...

CVSI : 0.0292 (-1.35%)
CV Sciences, Inc. (CVSI) Reports Q2 Loss, Lags Revenue Estimates

CV Sciences, Inc. (CVSI) delivered earnings and revenue surprises of 0% and 15.21%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

CVSI : 0.0292 (-1.35%)
ATNM : 5.92 (-1.66%)
CV Sciences, Inc. Reports Second Quarter 2022 Financial Results

/PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in...

CVSI : 0.0292 (-1.35%)
CV SCIENCES, INC. TO ANNOUNCE FIRST QUARTER 2022 RESULTS ON AUGUST 15, 2022

/PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol...

CVSI : 0.0292 (-1.35%)
VAXART, INC. (VXRT) Reports Q2 Loss, Lags Revenue Estimates

VAXART, INC. (VXRT) delivered earnings and revenue surprises of -9.52% and 100%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

VXRT : 4.16 (-4.37%)
CVSI : 0.0292 (-1.35%)
Ardelyx (ARDX) Reports Q2 Loss, Tops Revenue Estimates

Ardelyx (ARDX) delivered earnings and revenue surprises of 0% and 307.42%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

ARDX : 1.0000 (+3.09%)
CVSI : 0.0292 (-1.35%)
CV Sciences, Inc. Reports First Quarter 2022 Financial Results

SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and...

CVSI : 0.0292 (-1.35%)
CV Sciences, Inc. Reports Fiscal Year-End 2021 Financial Results

SAN DIEGO, March 31, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier...

CVSI : 0.0292 (-1.35%)
CV Sciences, Inc. to Announce Fourth Quarter and Full Year 2021 Results on March 31, 2022

SAN DIEGO, March 28, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier...

CVSI : 0.0292 (-1.35%)
UPDATE -- CV Sciences Adds +PlusCBD Relief Softgels to Wellness Line of CBD Products

New softgels deliver seven times more CBDA and CBD than original raw formula to support a healthy inflammatory response and to manage occasional soreness...

CVSI : 0.0292 (-1.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.0323
2nd Resistance Point 0.0314
1st Resistance Point 0.0303
Last Price 0.0292
1st Support Level 0.0283
2nd Support Level 0.0274
3rd Support Level 0.0263

See More

52-Week High 0.3298
Fibonacci 61.8% 0.2147
Fibonacci 50% 0.1792
Fibonacci 38.2% 0.1436
Last Price 0.0292
52-Week Low 0.0285

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar